THROMBOGENICS

🇺🇸United States
Ownership
-
Established
1985-01-01
Employees
-
Market Cap
-
Website
http://www.thrombogenics.com

A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt)

First Posted Date
2007-02-15
Last Posted Date
2014-12-17
Lead Sponsor
ThromboGenics
Target Recruit Count
60
Registration Number
NCT00435539
Locations
🇧🇪

ZNA OCMW Antwerpen, Antwerpen, Belgium

🇧🇪

University Hospital of Ghent, Ghent, Belgium

🇧🇪

Universitaire Ziekenhuizen K.U.Leuven, Leuven, Belgium

and more 1 locations

Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2007-01-29
Last Posted Date
2014-04-07
Lead Sponsor
ThromboGenics
Target Recruit Count
6
Registration Number
NCT00428129
Locations
🇮🇪

Section of Interventional Radiology, Department of Radiology, University College Hospital, Newcastle Road, Galway, Co Galway, Ireland

A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III)

First Posted Date
2006-12-19
Last Posted Date
2014-12-17
Lead Sponsor
ThromboGenics
Target Recruit Count
125
Registration Number
NCT00412958
Locations
🇺🇸

Mailing add: New England Eye Center - Tufts, Boston, Massachusetts, United States

🇺🇸

Associated Retinal Consultants, P.C., Royal Oak, Michigan, United States

🇺🇸

Allegheny Ophthalmic & Orbital Associates, P.C., Pittsburgh, Pennsylvania, United States

and more 17 locations

A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME)

First Posted Date
2006-12-18
Last Posted Date
2014-12-17
Lead Sponsor
ThromboGenics
Target Recruit Count
51
Registration Number
NCT00412451
Locations
🇪🇸

Instituto Technologico de Oftalmologia SL., Santiago de Compostela, Spain

🇳🇱

Academic Hospital Groningen, Groningen, Netherlands

🇳🇱

Het Oogziekenhuis Rotterdam, Rotterdam, Netherlands

and more 12 locations

Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2005-07-22
Last Posted Date
2014-04-07
Lead Sponsor
ThromboGenics
Target Recruit Count
2
Registration Number
NCT00123266
Locations
🇩🇪

Universitatsklinikum Freiburg, Freiburg, Germany

🇩🇪

Universitätsklinikum Erlangen, Erlangen, Germany

🇩🇪

HSK Dr. Horst Schmidt Hospital, Wiesbaden, Germany

and more 4 locations

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2005-07-22
Last Posted Date
2014-04-07
Lead Sponsor
ThromboGenics
Target Recruit Count
19
Registration Number
NCT00123292
Locations
🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

First Posted Date
2005-07-22
Last Posted Date
2014-04-07
Lead Sponsor
ThromboGenics
Target Recruit Count
60
Registration Number
NCT00123279
Locations
🇳🇱

Oogziekenhuis Rotterdam, Rotterdam, Netherlands

🇧🇪

University Hospital Gasthuisberg, Leuven, Belgium

🇳🇱

Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-07-22
Last Posted Date
2014-11-07
Lead Sponsor
ThromboGenics
Target Recruit Count
40
Registration Number
NCT00123305
Locations
🇦🇹

Allgemeines Offentliches Krankenhaus der, Linz, Austria

🇧🇪

Cliniques Universitaires St Luc, Brussels, Belgium

🇦🇹

Landesnervenklinik Wagner-Jauregg, Linz, Austria

and more 13 locations
© Copyright 2024. All Rights Reserved by MedPath